CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Opella : Une nouvelle étude démontre que le traitement efficace de la toux ne se limite pas au soulagement des symptômes.

Data ReadoutpositiveMucosolvanBisolvonPositive
AI Analysis

Summary

Opella announced results from a real-world study of Mucosolvan and Bisolvon demonstrating that cough treatment effectiveness should be evaluated based on overall well-being impact rather than symptom relief alone.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Real-world study demonstrates that effective cough treatment success should be measured by impact on overall well-being, not just symptom relief

Importance:3/10
Sentiment:
0.60
real-world evidencecough treatmentclinical datapharmacist education
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on October 14, 2026 11:01 PM

Read Original